Table 1 Association between SOX21-AS1 expression and clinicopathological characteristics in EC patients (n = 30)
Parameters | Total | SOX21-AS1 expression | χ2 | P value | |
|---|---|---|---|---|---|
Low (no.) | High (no.) | ||||
Age (years) | 0.373 | 0.542 | |||
< 55 | 20 | 16 | 4 | ||
≥ 55 | 10 | 7 | 3 | ||
Histology grade | 2.301 | 0.129 | |||
G1 + G2 | 18 | 15 | 3 | ||
G3 | 12 | 7 | 5 | ||
FIGO stages | 5.44 | 0.020 | |||
I/II | 19 | 15 | 4 | ||
I II/IV | 11 | 4 | 7 | ||
Pathologic type | 2.981 | 0.084 | |||
Endometrioid | 24 | 20 | 4 | ||
Non-endometrioid | 6 | 3 | 3 | ||
Lymph node metastasis | 8.727 | 0.003 | |||
No | 22 | 21 | 1 | ||
Yes | 8 | 4 | 4 | ||